+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biosimulation Market by Offering (Services, Software), Delivery Model (Ownership Models, Subscription Models), Application, End-User - Global Forecast 2025-2030- Product Image
Biosimulation Market by Offering (Services, Software), Delivery Model (Ownership Models, Subscription Models), Application, End-User - Global Forecast 2025-2030- Product Image
Sale

Biosimulation Market by Offering (Services, Software), Delivery Model (Ownership Models, Subscription Models), Application, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 193 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6084021
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Biosimulation continues to transform pharmaceutical research by improving the precision and speed of drug discovery and development decisions. This report offers senior leaders a clear, actionable view of how biosimulation solutions are evolving to meet rising demands for accuracy, efficiency, and regulatory compliance in a rapidly changing marketplace.

Market Snapshot: Biosimulation Market Size and Growth Trends

The biosimulation market grew from USD 3.55 billion in 2024 to USD 4.07 billion in 2025. Currently, it is projected to expand at a CAGR of 14.62%, reaching USD 8.07 billion by 2030. Growth is being fueled by ongoing digital innovation, greater industry adoption of simulation-based strategies prior to clinical trials, and increasing validation by regulators. Senior decision-makers should consider these trends as they navigate investments and partnerships.

Biosimulation Market Scope & Segmentation

This report provides an in-depth analysis across key areas impacting biosimulation, revealing where opportunity and competition intersect within the evolving landscape.

  • Offering: Services (contract research and in-house analytical support); Software (molecular modeling, PBPK, PK/PD, toxicity prediction, trial design)
  • Delivery Models: Ownership; Subscription
  • Applications: Drug development (clinical trials, preclinical testing including ADME/Tox and PK/PD); Drug discovery (lead identification and optimization, target identification and validation)
  • End-Users: Contract research organizations; Pharmaceutical and biotechnology companies; Regulatory authorities; Research institutes
  • Regional Coverage: Americas (including United States, Canada, Mexico, Brazil, Argentina); Europe, Middle East, and Africa (featuring major and emerging economies); Asia-Pacific (China, India, Japan, Australia, South Korea, Southeast Asian markets)
  • Industry Players: Advanced Chemistry Development, Inc.; Aitia; Allucent; Biomed Simulation, Inc.; BioSimulation Consulting Inc.; Cadence Design Systems, Inc.; Cell Works Group, Inc.; Certara, Inc.; Chemical Computing Group ULC; Crystal Pharmatech Co., Ltd.; Cytel Inc.; Dassault Systèmes SE; ICON PLC; In Silico Biosciences, Inc.; INOSIM Software GmbH; Instem PLC; Model Vitals; Physiomics PLC; Quotient Sciences Limited; Resolution Medical; Schrodinger, Inc.; Simulations Plus, Inc.; Thermo Fisher Scientific Inc.; VeriSIM Life; VIRTUALMAN; Yokogawa Electric Corporation

Key Technologies Highlighted:

  • Advanced machine learning frameworks and AI-powered predictive modeling
  • High-performance computing, including cloud-based simulation platforms
  • Interoperable software enabling integrated workflows and data sharing

Key Takeaways for Decision-Makers

  • Biosimulation is an established, growing pillar in drug R&D pipelines, enabling earlier stage go/no-go decisions and greater safety profile prediction.
  • Regulatory authorities are increasingly endorsing simulated evidence, supporting broader industry adoption and encouraging new submission standards.
  • Subscription-based software models drive flexibility and cost efficiency, replacing traditional ownership structures and accelerating technology updates.
  • Cloud-based infrastructure is democratizing access to complex simulations, allowing smaller organizations and academia to compete alongside industry leaders.
  • Companies are strategically investing in open standards and data interoperability to streamline collaborations, optimize workflows, and accelerate time-to-results.

Tariff Impact on Global Biosimulation Providers

New United States tariff measures in 2025 have added cost pressures to biosimulation service providers and software developers, particularly those relying on international hardware and software supply chains. Vendors are mitigating these challenges by shifting to localized service delivery, establishing regional data centers, and redesigning pricing and licensing models to balance budgetary impact while maintaining high quality standards. Collaborative partnerships are also emerging as a strategic lever to manage cross-border complexities and sustain market growth.

Methodology & Data Sources

This analysis is based on primary interviews with senior executives, scientific leaders, and regulatory experts representing multiple global regions. Secondary data sources include peer-reviewed publications, proprietary industry reports, regulatory guidance, and conference proceedings. Analytical methods such as SWOT, PESTLE, and growth mapping were triangulated and validated against expert insights, ensuring coverage and objectivity.

Why This Report Matters

  • Enables executives to benchmark against top competitors and evaluate the impact of technology, regulatory shifts, and tariff measures.
  • Provides actionable segmentation to guide investment, product development, and partnership strategies globally.
  • Offers a comprehensive foundation for understanding technology adoption, market drivers, and evolving end-user requirements.

Conclusion

The biosimulation market offers a dynamic environment propelled by technological innovation, regulatory acceptance, and shifting business models. Strategic engagement with modular solutions, cross-disciplinary talent, and local market adaptation will be crucial for future growth and leadership in this sector.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of AI-driven predictive modeling to optimize personalized treatment simulations
5.2. Expansion of cloud-based biosimulation platforms for collaborative research across global teams
5.3. Emergence of digital twin technology for patient-specific drug response forecasting
5.4. Regulatory frameworks evolving to include in silico trials for accelerated drug approval pathways
5.5. Incorporation of multiscale modeling techniques to bridge molecular and physiological processes
5.6. Adoption of high-performance computing infrastructures to reduce simulation runtimes in drug discovery
5.7. Development of mechanistic pharmacokinetic and pharmacodynamic models to enhance clinical predictivity
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Biosimulation Market, by Offering
8.1. Introduction
8.2. Services
8.2.1. Contract Services
8.2.2. In-House Services
8.3. Software
8.3.1. Molecular Modeling & Simulation Software
8.3.2. PBPK Modeling & Simulation Software
8.3.3. PK/PD Modeling & Simulation Software
8.3.4. Toxicity Prediction Software
8.3.5. Trial Design Software
9. Biosimulation Market, by Delivery Model
9.1. Introduction
9.2. Ownership Models
9.3. Subscription Models
10. Biosimulation Market, by Application
10.1. Introduction
10.2. Drug Development
10.2.1. Clinical Trials
10.2.2. Preclinical Testing
10.2.2.1. ADME/Tox
10.2.2.2. PK/PD
10.3. Drug Discovery
10.3.1. Lead Identification & Optimization
10.3.2. Target Identification & Validation
11. Biosimulation Market, by End-User
11.1. Introduction
11.2. Contract Research Organizations
11.3. Pharmaceutical & Biotechnology Companies
11.4. Regulatory Authorities
11.5. Research Institutes
12. Americas Biosimulation Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Biosimulation Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Biosimulation Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Advanced Chemistry Development, Inc.
15.3.2. Aitia
15.3.3. Allucent
15.3.4. Biomed Simulation, Inc.
15.3.5. BioSimulation Consulting Inc.
15.3.6. Cadence Design Systems, Inc.
15.3.7. Cell Works Group, Inc.
15.3.8. Certara, Inc.
15.3.9. Chemical Computing Group ULC
15.3.10. Crystal Pharmatech Co., Ltd.
15.3.11. Cytel Inc.
15.3.12. Dassault Systèmes SE
15.3.13. ICON PLC
15.3.14. In Silico Biosciences, Inc.
15.3.15. INOSIM Software GmbH
15.3.16. Instem PLC
15.3.17. Model Vitals
15.3.18. Physiomics PLC
15.3.19. Quotient Sciences Limited
15.3.20. Resolution Medical
15.3.21. Schrodinger, Inc.
15.3.22. Simulations Plus, Inc.
15.3.23. Thermo Fisher Scientific Inc.
15.3.24. VeriSIM Life
15.3.25. VIRTUALMAN
15.3.26. Yokogawa Electric Corporation
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. BIOSIMULATION MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL BIOSIMULATION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL BIOSIMULATION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL BIOSIMULATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BIOSIMULATION MARKET SIZE, BY OFFERING, 2024 VS 2030 (%)
FIGURE 6. GLOBAL BIOSIMULATION MARKET SIZE, BY OFFERING, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIOSIMULATION MARKET SIZE, BY DELIVERY MODEL, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIOSIMULATION MARKET SIZE, BY DELIVERY MODEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOSIMULATION MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIOSIMULATION MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOSIMULATION MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIOSIMULATION MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS BIOSIMULATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS BIOSIMULATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES BIOSIMULATION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES BIOSIMULATION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BIOSIMULATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BIOSIMULATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC BIOSIMULATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC BIOSIMULATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. BIOSIMULATION MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. BIOSIMULATION MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. BIOSIMULATION MARKET: RESEARCHAI
FIGURE 24. BIOSIMULATION MARKET: RESEARCHSTATISTICS
FIGURE 25. BIOSIMULATION MARKET: RESEARCHCONTACTS
FIGURE 26. BIOSIMULATION MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. BIOSIMULATION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIOSIMULATION MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL BIOSIMULATION MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL BIOSIMULATION MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL BIOSIMULATION MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL BIOSIMULATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL BIOSIMULATION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL BIOSIMULATION MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL BIOSIMULATION MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL BIOSIMULATION MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL BIOSIMULATION MARKET SIZE, BY SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL BIOSIMULATION MARKET SIZE, BY CONTRACT SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL BIOSIMULATION MARKET SIZE, BY CONTRACT SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL BIOSIMULATION MARKET SIZE, BY IN-HOUSE SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL BIOSIMULATION MARKET SIZE, BY IN-HOUSE SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL BIOSIMULATION MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL BIOSIMULATION MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL BIOSIMULATION MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL BIOSIMULATION MARKET SIZE, BY SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL BIOSIMULATION MARKET SIZE, BY MOLECULAR MODELING & SIMULATION SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL BIOSIMULATION MARKET SIZE, BY MOLECULAR MODELING & SIMULATION SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL BIOSIMULATION MARKET SIZE, BY PBPK MODELING & SIMULATION SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL BIOSIMULATION MARKET SIZE, BY PBPK MODELING & SIMULATION SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL BIOSIMULATION MARKET SIZE, BY PK/PD MODELING & SIMULATION SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL BIOSIMULATION MARKET SIZE, BY PK/PD MODELING & SIMULATION SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL BIOSIMULATION MARKET SIZE, BY TOXICITY PREDICTION SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL BIOSIMULATION MARKET SIZE, BY TOXICITY PREDICTION SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL BIOSIMULATION MARKET SIZE, BY TRIAL DESIGN SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL BIOSIMULATION MARKET SIZE, BY TRIAL DESIGN SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL BIOSIMULATION MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL BIOSIMULATION MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL BIOSIMULATION MARKET SIZE, BY DELIVERY MODEL, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL BIOSIMULATION MARKET SIZE, BY DELIVERY MODEL, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL BIOSIMULATION MARKET SIZE, BY OWNERSHIP MODELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL BIOSIMULATION MARKET SIZE, BY OWNERSHIP MODELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL BIOSIMULATION MARKET SIZE, BY SUBSCRIPTION MODELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL BIOSIMULATION MARKET SIZE, BY SUBSCRIPTION MODELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL BIOSIMULATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL BIOSIMULATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL BIOSIMULATION MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL BIOSIMULATION MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL BIOSIMULATION MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL BIOSIMULATION MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL BIOSIMULATION MARKET SIZE, BY PRECLINICAL TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL BIOSIMULATION MARKET SIZE, BY PRECLINICAL TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL BIOSIMULATION MARKET SIZE, BY ADME/TOX, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL BIOSIMULATION MARKET SIZE, BY ADME/TOX, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL BIOSIMULATION MARKET SIZE, BY PK/PD, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL BIOSIMULATION MARKET SIZE, BY PK/PD, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL BIOSIMULATION MARKET SIZE, BY PRECLINICAL TESTING, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL BIOSIMULATION MARKET SIZE, BY PRECLINICAL TESTING, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL BIOSIMULATION MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL BIOSIMULATION MARKET SIZE, BY DRUG DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL BIOSIMULATION MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL BIOSIMULATION MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL BIOSIMULATION MARKET SIZE, BY LEAD IDENTIFICATION & OPTIMIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL BIOSIMULATION MARKET SIZE, BY LEAD IDENTIFICATION & OPTIMIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL BIOSIMULATION MARKET SIZE, BY TARGET IDENTIFICATION & VALIDATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL BIOSIMULATION MARKET SIZE, BY TARGET IDENTIFICATION & VALIDATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL BIOSIMULATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL BIOSIMULATION MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL BIOSIMULATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL BIOSIMULATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL BIOSIMULATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL BIOSIMULATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL BIOSIMULATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL BIOSIMULATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL BIOSIMULATION MARKET SIZE, BY REGULATORY AUTHORITIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL BIOSIMULATION MARKET SIZE, BY REGULATORY AUTHORITIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL BIOSIMULATION MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL BIOSIMULATION MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS BIOSIMULATION MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS BIOSIMULATION MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS BIOSIMULATION MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS BIOSIMULATION MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS BIOSIMULATION MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS BIOSIMULATION MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS BIOSIMULATION MARKET SIZE, BY DELIVERY MODEL, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS BIOSIMULATION MARKET SIZE, BY DELIVERY MODEL, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS BIOSIMULATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS BIOSIMULATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS BIOSIMULATION MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS BIOSIMULATION MARKET SIZE, BY DRUG DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS BIOSIMULATION MARKET SIZE, BY PRECLINICAL TESTING, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS BIOSIMULATION MARKET SIZE, BY PRECLINICAL TESTING, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS BIOSIMULATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS BIOSIMULATION MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS BIOSIMULATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS BIOSIMULATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS BIOSIMULATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS BIOSIMULATION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES BIOSIMULATION MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES BIOSIMULATION MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES BIOSIMULATION MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES BIOSIMULATION MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES BIOSIMULATION MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES BIOSIMULATION MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES BIOSIMULATION MARKET SIZE, BY DELIVERY MODEL, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES BIOSIMULATION MARKET SIZE, BY DELIVERY MODEL, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES BIOSIMULATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES BIOSIMULATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES BIOSIMULATION MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES BIOSIMULATION MARKET SIZE, BY DRUG DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES BIOSIMULATION MARKET SIZE, BY PRECLINICAL TESTING, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES BIOSIMULATION MARKET SIZE, BY PRECLINICAL TESTING, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES BIOSIMULATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES BIOSIMULATION MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES BIOSIMULATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES BIOSIMULATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES BIOSIMULATION MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES BIOSIMULATION MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 113. CANADA BIOSIMULATION MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
TABLE 114. CANADA BIOSIMULATION MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
TABLE 115. CANADA BIOSIMULATION MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 116. CANADA BIOSIMULATION MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 117. CANADA BIOSIMULATION MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 118. CANADA BIOSIMULATION MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 119. CANADA BIOSIMULATION MARKET SIZE, BY DELIVERY MODEL, 2018-2024 (USD MILLION)
TABLE 120. CANADA BIOSIMULATION MARKET SIZE, BY DELIVERY MODEL, 2025-2030 (USD MILLION)
TABLE 121. CANADA BIOSIMULATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 122. CANADA BIOSIMULATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 123. CANADA BIOSIMULATION MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 124. CANADA BIOSIMULATION MARKET SIZE, BY DRUG DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 125. CANADA BIOSIMULATION MARKET SIZE, BY PRECLINICAL TESTING, 2018-2024 (USD MILLION)
TABLE 126. CANADA BIOSIMULATION MARKET SIZE, BY PRECLINICAL TESTING, 2025-2030 (USD MILLION)
TABLE 127. CANADA BIOSIMULATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 128. CANADA BIOSIMULATION MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 129. CANADA BIOSIMULATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 130. CANADA BIOSIMULATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 131. MEXICO BIOSIMULATION MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
TABLE 132. MEXICO BIOSIMULATION MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
TABLE 133. MEXICO BIOSIMULATION MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 134. MEXICO BIOSIMULATION MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 135. MEXICO BIOSIMULATION MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 136. MEXICO BIOSIMULATION MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 137. MEXICO BIOSIMULATION MARKET SIZE, BY DELIVERY MODEL, 2018-2024 (USD MILLION)
TABLE 138. MEXICO BIOSIMULATION MARKET SIZE, BY DELIVERY MODEL, 2025-2030 (USD MILLION)
TABLE 139. MEXICO BIOSIMULATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 140. MEXICO BIOSIMULATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 141. MEXICO BIOSIMULATION MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 142. MEXICO BIOSIMULATION MARKET SIZE, BY DRUG DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 143. MEXICO BIOSIMULATION MARKET SIZE, BY PRECLINICAL TESTING, 2018-2024 (USD MILLION)
TABLE 144. MEXICO BIOSIMULATION MARKET SIZE, BY PRECLINICAL TESTING, 2025-2030 (USD MILLION)
TABLE 145. MEXICO BIOSIMULATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 146. MEXICO BIOSIMULATION MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 147. MEXICO BIOSIMULATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 148. MEXICO BIOSIMULATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL BIOSIMULATION MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL BIOSIMULATION MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL BIOSIMULATION MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL BIOSIMULATION MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL BIOSIMULATION MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL BIOSIMULATION MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL BIOSIMULATION MARKET SIZE, BY DELIVERY MODEL, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL BIOSIMULATION MARKET SIZE, BY DELIVERY MODEL, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL BIOSIMULATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL BIOSIMULATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL BIOSIMULATION MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL BIOSIMULATION MARKET SIZE, BY DRUG DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 161. BRAZIL BIOSIMULATION MARKET SIZE, BY PRECLINICAL TESTING, 2018-2024 (USD MILLION)
TABLE 162. BRAZIL BIOSIMULATION MARKET SIZE, BY PRECLINICAL TESTING, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL BIOSIMULATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL BIOSIMULATION MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL BIOSIMULATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL BIOSIMULATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA BIOSIMULATION MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA BIOSIMULATION MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA BIOSIMULATION MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA BIOSIMULATION MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA BIOSIMULATION MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA BIOSIMULATION MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 173. ARGENTINA BIOSIMULATION MARKET SIZE, BY DELIVERY MODEL, 2018-2024 (USD MILLION)
TABLE 174. ARGENTINA BIOSIMULATION MARKET SIZE, BY DELIVERY MODEL, 2025-2030 (USD MILLION)
TABLE 175. ARGENTINA BIOSIMULATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 176. ARGENTINA BIOSIMULATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 177. ARGENTINA BIOSIMULATION MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 178. ARGENTINA BIOSIMULATION MARKET SIZE, BY DRUG DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 179. ARGENTINA BIOSIMULATION MARKET SIZE, BY PRECLINICAL TESTING, 2018-2024 (USD MILLION)
TABLE 180. ARGENTINA BIOSIMULATION MARKET SIZE, BY PRECLINICAL TESTING, 2025-2030 (USD MILLION)
TABLE 181. ARGENTINA BIOSIMULATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 182. ARGENTINA BIOSIMULATION MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 183. ARGENTINA BIOSIMULATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 184. ARGENTINA BIOSIMULATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA BIOSIMULATION MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA BIOSIMULATION MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA BIOSIMULATION MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA BIOSIMULATION MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA BIOSIMULATION MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA BIOSIMULATION MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA BIOSIMULATION MARKET SIZE, BY DELIVERY MODEL, 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA BIOSIMULATION MARKET SIZE, BY DELIVERY MODEL, 2025-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA BIOSIMULATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA BIOSIMULATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA BIOSIMULATION MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA BIOSIMULATION MARKET SIZE, BY DRUG DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA BIOSIMULATION MARKET SIZE, BY PRECLINICAL TESTING, 2018-2024 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA BIOSIMULATION MARKET SIZE, BY PRECLINICAL TESTING, 2025-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA BIOSIMULATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA BIOSIMULATION MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA BIOSIMULATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA BIOSIMULATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA BIOSIMULATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA BIOSIMULATION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM BIOSIMULATION MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
TABLE 206. UNITED KINGDOM BIOSIMULATION MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM BIOSIMULATION MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 208. UNITED KINGDOM BIOSIMULATION MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM BIOSIMULATION MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 210. UNITED KINGDOM BIOSIMULATION MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM BIOSIMULATION MARKET SIZE, BY DELIVERY MODEL, 2018-2024 (USD MILLION)
TABLE 212. UNITED KINGDOM BIOSIMULATION MARKET SIZE, BY DELIVERY MODEL, 2025-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM BIOSIMULATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 214. UNITED KINGDOM BIOSIMULATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 215. UNITED KINGDOM BIOSIMULATION MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 216. UNITED KINGDOM BIOSIMULATION MARKET SIZE, BY DRUG DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 217. UNITED KINGDOM BIOSIMULATION MARKET SIZE, BY PRECLINICAL TESTING, 2018-2024 (USD MILLION)
TABLE 218. UNITED KINGDOM BIOSIMULATION MARKET SIZE, BY PRECLINICAL TESTING, 2025-2030 (USD MILLION)
TABLE 219. UNITED KINGDOM BIOSIMULATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 220. UNITED KINGDOM BIOSIMULATION MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 221. UNITED KINGDOM BIOSIMULATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 222. UNITED KINGDOM BIOSIMULATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 223. GERMANY BIOSIMULATION MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
TABLE 224. GERMANY BIOSIMULATION MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
TABLE 225. GERMANY BIOSIMULATION MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 226. GERMANY BIOSIMULATION MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 227. GERMANY BIOSIMULATION MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 228. GERMANY BIOSIMULATION MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 229. GERMANY BIOSIMULATION MARKET SIZE, BY DELIVERY MODEL, 2018-2024 (USD MILLION)
TABLE 230. GERMANY BIOSIMULATION MARKET SIZE, BY DELIVERY MODEL, 2025-2030 (USD MILLION)
TABLE 231. GERMANY BIOSIMULATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 232. GERMANY BIOSIMULATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 233. GERMANY BIOSIMULATION MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 234. GERMANY BIOSIMULATION MARKET SIZE, BY DRUG DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 235. GERMANY BIOSIMULATION MARKET SIZE, BY PRECLINICAL TESTING, 2018-2024 (USD MILLION)
TABLE 236. GERMANY BIOSIMULATION MARKET SIZE, BY PRECLINICAL TESTING, 2025-2030 (USD MILLION)
TABLE 237. GERMANY BIOSIMULATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 238. GERMANY BIOSIMULATION MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 239. GERMANY BIOSIMULATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 240. GERMANY BIOSIMULATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 241. FRANCE BIOSIMULATION MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
TABLE 242. FRANCE BIOSIMULATION MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
TABLE 243. FRANCE BIOSIMULATION MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 244. FRANCE BIOSIMULATION MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 245. FRANCE BIOSIMULATION MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 246. FRANCE BIOSIMULATION MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 247. FRANCE BIOSIMULATION MARKET SIZE, BY DELIVERY MODEL, 2018-2024 (USD MILLION)
TABLE 248. FRANCE BIOSIMULATION MARKET SIZE, BY DELIVERY MODEL, 2025-2030 (USD MILLION)
TABLE 249. FRANCE BIOSIMULATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 250. FRANCE BIOSIMULATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 251. FRANCE BIOSIMULATION MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 252. FRANCE BIOSIMULATION MARKET SIZE, BY DRUG DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 253. FRANCE BIOSIMULATION MARKET SIZE, BY PRECLINICAL TESTING, 2018-2024 (USD MILLION)
TABLE 254. FRANCE BIOSIMULATION MARKET SIZE, BY PRECLINICAL TESTING, 2025-2030 (USD MILLION)
TABLE 255. FRANCE BIOSIMULATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 256. FRANCE BIOSIMULATION MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 257. FRANCE BIOSIMULATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 258. FRANCE BIOSIMULATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 259. RUSSIA BIOSIMULATION MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
TABLE 260. RUSSIA BIOSIMULATION MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
TABLE 261. RUSSIA BIOSIMULATION MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 262. RUSSIA BIOSIMULATION MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 263. RUSSIA BIOSIMULATION MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 264. RUSSIA BIOSIMULATION MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 265. RUSSIA BIOSIMULATION MARKET SIZE, BY DELIVERY MODEL, 2018-2024 (USD MILLION)
TABLE 266. RUSSIA BIOSIMULATION MARKET SIZE, BY DELIVERY MODEL, 2025-2030 (USD MILLION)
TABLE 267. RUSSIA BIOSIMULATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 268. RUSSIA BIOSIMULATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 269. RUSSIA BIOSIMULATION MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 270. RUSSIA BIOSIMULATION MARKET SIZE, BY DRUG DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 271. RUSSIA BIOSIMULATION MARKET SIZE, BY PRECLINICAL TESTING, 2018-2024 (USD MILLION)
TABLE 272. RUSSIA BIOSIMULATION MARKET SIZE, BY PRECLINICAL TESTING, 2025-2030 (USD MILLION)
TABLE 273. RUSSIA BIOSIMULATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 274. RUSSIA BIOSIMULATION MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 275. RUSSIA BIOSIMULATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 276. RUSSIA BIOSIMULATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 277. ITALY BIOSIMULATION MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
TABLE 278. ITALY BIOSIMULATION MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
TABLE 279. ITALY BIOSIMULATION MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 280. ITALY BIOSIMULATION MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 281. ITALY BIOSIMULATION MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 282. ITALY BIOSIMULATION MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 283. ITALY BIOSIMULATION MARKET SIZE, BY DELIVERY MODEL, 2018-2024 (USD MILLION)
TABLE 284. ITALY BIOSIMULATION MARKET SIZE, BY DELIVERY MODEL, 2025-2030 (USD MILLION)
TABLE 285. ITALY BIOSIMULATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 286. ITALY BIOSIMULATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 287. ITALY BIOSIMULATION MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 288. ITALY BIOSIMULATION MARKET SIZE, BY DRUG DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 289. ITALY BIOSIMULATION MARKET SIZE, BY PRECLINICAL TESTING, 2018-2024 (USD MILLION)
TABLE 290. ITALY BIOSIMULATION MARKET SIZE, BY PRECLINICAL TESTING, 2025-2030 (USD MILLION)
TABLE 291. ITALY BIOSIMULATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 292. ITALY BIOSIMULATION MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 293. ITALY BIOSIMULATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 294. ITALY BIOSIMULATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 295. SPAIN BIOSIMULATION MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
TABLE 296. SPAIN BIOSIMULATION MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
TABLE 297. SPAIN BIOSIMULATION MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 298. SPAIN BIOSIMULATION MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 299. SPAIN BIOSIMULATION MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 300. SPAIN BIOSIMULATION MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 301. SPAIN BIOSIMULATION MARKET SIZE, BY DELIVERY MODEL, 2018-2024 (USD MILLION)
TABLE 302. SPAIN BIOSIMULATION MARKET SIZE, BY DELIVERY MODEL, 2025-2030 (USD MILLION)
TABLE 303. SPAIN BIOSIMULATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 304. SPAIN BIOSIMULATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 305. SPAIN BIOSIMULATION MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 306. SPAIN BIOSIMULATION MARKET SIZE, BY DRUG DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 307. SPAIN BIOSIMULATION MARKET SIZE, BY PRECLINICAL TESTING, 2018-2024 (USD MILLION)
TABLE 308. SPAIN BIOSIMULATION MARKET SIZE, BY PRECLINICAL TESTING, 2025-2030 (USD MILLION)
TABLE 309. SPAIN BIOSIMULATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 310. SPAIN BIOSIMULATION MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 311. SPAIN BIOSIMULATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 312. SPAIN BIOSIMULATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 313. UNITED ARAB EMIRATES BIOSIMULATION MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
TABLE 314. UNITED ARAB EMIRATES BIOSIMULATION MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
TABLE 315. UNITED ARAB EMIRATES BIOSIMULATION MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 316. UNITED ARAB EMIRATES BIOSIMULATION MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 317. UNITED ARAB EMIRATES BIOSIMULATION MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 318. UNITED ARAB EMIRATES BIOSIMULATION MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 319. UNITED ARAB EMIRATES BIOSIMULATION MARKET SIZE, BY DELIVERY MODEL, 2018-2024 (USD MILLION)
TABLE 320. UNITED ARAB EMIRATES BIOSIMULATION MARKET SIZE, BY DELIVERY MODEL, 2025-2030 (USD MILLION)
TABLE 321. UNITED ARAB EMIRATES BIOSIMULATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 322. UNITED ARAB EMIRATES BIOSIMULATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 323. UNITED ARAB EMIRATES BIOSIMULATION MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 324. UNITED ARAB EMIRATES BIOSIMULATION MARKET SIZE, BY DRUG DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 325. UNITED ARAB EMIRATES BIOSIMULATION MARKET SIZE, BY PRECLINICAL TESTING, 2018-2024 (USD MILLION)
TABLE 326. UNITED ARAB EMIRATES BIOSIMULATION MARKET SIZE, BY PRECLINICAL TESTING, 2025-2030 (USD MILLION)
TABLE 327. UNITED ARAB EMIRATES BIOSIMULATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 328. UNITED ARAB EMIRATES BIOSIMULATION MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 329. UNITED ARAB EMIRATES BIOSIMULATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 330. UNITED ARAB EMIRATES BIOSIMULATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 331. SAUDI ARABIA BIOSIMULATION MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
TABLE 332. SAUDI ARABIA BIOSIMULATION MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
TABLE 333. SAUDI ARABIA BIOSIMULATION MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 334. SAUDI ARABIA BIOSIMULATION MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 335. SAUDI ARABIA BIOSIMULATION MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 336. SAUDI ARABIA BIOSIMULATION MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 337. SAUDI ARABIA BIOSIMULATION MARKET SIZE, BY DELIVERY MODEL, 2018-2024 (USD MILLION)
TABLE 338. SAUDI ARABIA BIOSIMULATION MARKET SIZE, BY DELIVERY MODEL, 2025-2030 (USD MILLION)
TABLE 339. SAUDI ARABIA BIOSIMULATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 340. SAUDI ARABIA BIOSIMULATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 341. SAUDI ARABIA BIOSIMULATION MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 342. SAUDI ARABIA BIOSIMULATION MARKET SIZE, BY DRUG DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 343. SAUDI ARABIA BIOSIMULATION MARKET SIZE, BY PRECLINICAL TESTING, 2018-2024 (USD MILLION)
TABLE 344. SAUDI ARABIA BIOSIMULATION MARKET SIZE, BY PRECLINICAL TESTING, 2025-2030 (USD MILLION)
TABLE 345. SAUDI ARABIA BIOSIMULATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 346. SAUDI ARABIA BIOSIMULATION MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 347. SAUDI ARABIA BIOSIMULATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 348. SAUDI ARABIA BIOSIMULATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 349. SOUTH AFRICA BIOSIMULATION MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
TABLE 350. SOUTH AFRICA BIOSIMULATION MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
TABLE 351. SOUTH AFRICA BIOSIMULATION MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 352. SOUTH AFRICA BIOSIMULATION MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 353. SOUTH AFRICA BIOSIMULATION MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
TABLE 354. SOUTH AFRICA BIOSIMULATION MARKET SIZE, BY SOFTWARE, 2025-2030 (USD MILLION)
TABLE 355. SOUTH AFRICA BIOSIMULATION MARKET SIZE, BY DELIVERY MODEL, 2018-2024 (USD MILLION)
TABLE 356. SOUTH AFRICA BIOSIMULATION MARKET SIZE, BY DELIVERY MODEL, 2025-2030 (USD MILLION)
TABLE 357. SOUTH AFRICA BIOSIMULATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 358. SOUTH AFRICA BIOSIMULATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 359. SOUTH AFRICA BIOSIMULATION MARKET SIZE, BY DRUG DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 360. SOUTH AFRICA BIOSIMULATION MARKET S

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Biosimulation market report include:
  • Advanced Chemistry Development, Inc.
  • Aitia
  • Allucent
  • Biomed Simulation, Inc.
  • BioSimulation Consulting Inc.
  • Cadence Design Systems, Inc.
  • Cell Works Group, Inc.
  • Certara, Inc.
  • Chemical Computing Group ULC
  • Crystal Pharmatech Co., Ltd.
  • Cytel Inc.
  • Dassault Systèmes SE
  • ICON PLC
  • In Silico Biosciences, Inc.
  • INOSIM Software GmbH
  • Instem PLC
  • Model Vitals
  • Physiomics PLC
  • Quotient Sciences Limited
  • Resolution Medical
  • Schrodinger, Inc.
  • Simulations Plus, Inc.
  • Thermo Fisher Scientific Inc.
  • VeriSIM Life
  • VIRTUALMAN
  • Yokogawa Electric Corporation

Table Information

Report AttributeDetails
No. of Pages193
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 4.07 Billion
Forecasted Market Value ( USD ) by 2030 $ 8.07 Billion
Compound Annual Growth Rate14.6%
Regions CoveredGlobal
No. of Companies Mentioned27

Related Topics

Related Reports

Biosimulation Software Market by Application (Bioinformatics, Clinical Trial Simulation, Molecular Modeling & Simulation), End User (Academic & Research Institutes, Contract Research Organizations, Hospitals & Clinics), Product, Delivery Mode - Global Forecast 2025-2030 - Product Image

Biosimulation Software Market by Application (Bioinformatics, Clinical Trial Simulation, Molecular Modeling & Simulation), End User (Academic & Research Institutes, Contract Research Organizations, Hospitals & Clinics), Product, Delivery Mode - Global Forecast 2025-2030

  • Report
  • 199 Pages
  • Global
From
Biosimulation Market by Offering (Module, Integrated Platform), Application (Disease Modeling, PBPK, PKPD, Trial Simulation, Manufacturing & Supply Chain: Planning & Forecasting), Indication (Cancer, CNS, CVS), End User, & Region - Global Forecast to 2029 - Product Image

Biosimulation Market by Offering (Module, Integrated Platform), Application (Disease Modeling, PBPK, PKPD, Trial Simulation, Manufacturing & Supply Chain: Planning & Forecasting), Indication (Cancer, CNS, CVS), End User, & Region - Global Forecast to 2029

  • Report
  • 386 Pages
  • Global
From
Biosimulation Market Size, Share & Trends Analysis Report By Product (Software, Services), By Application, Therapeutic Area, By Deployment Model, By Pricing Model, By End Use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Biosimulation Market Size, Share & Trends Analysis Report By Product (Software, Services), By Application, Therapeutic Area, By Deployment Model, By Pricing Model, By End Use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 100 Pages
  • Global
From
Biosimulation Market (2024 Edition): Analysis By Type (Services, Software), By Application, By Deployment Model Outlook, By Region, By Country: Market Insights and Forecast (2020-2030) - Product Image

Biosimulation Market (2024 Edition): Analysis By Type (Services, Software), By Application, By Deployment Model Outlook, By Region, By Country: Market Insights and Forecast (2020-2030)

  • Report
  • 241 Pages
  • Global
From
Biosimulation Technology - Global Strategic Business Report - Product Image

Biosimulation Technology - Global Strategic Business Report

  • Report
  • 214 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.